Bülent Ündar

717 total citations
51 papers, 407 citations indexed

About

Bülent Ündar is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bülent Ündar has authored 51 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 15 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Bülent Ündar's work include Chronic Myeloid Leukemia Treatments (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Acute Myeloid Leukemia Research (8 papers). Bülent Ündar is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Acute Myeloid Leukemia Research (8 papers). Bülent Ündar collaborates with scholars based in Türkiye and United States. Bülent Ündar's co-authors include Fatih Demırkan, Mehmet Ali Özcan, Sabahattin Altunyurt, İnci Alacacıoğlu, Güner Hayri Özsan, Nurullah Akkoç, Faize Yüksel, Ömür Gökmen Sevindik, Hayri Özsan and Aydanur Kargı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Thrombosis and Haemostasis and European Radiology.

In The Last Decade

Bülent Ündar

49 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bülent Ündar Türkiye 12 215 109 101 59 50 51 407
Hideyuki Koharazawa Japan 12 191 0.9× 115 1.1× 80 0.8× 45 0.8× 42 0.8× 40 405
Sreejesh Sreedharanunni India 11 147 0.7× 49 0.4× 97 1.0× 61 1.0× 53 1.1× 95 351
Ayhan Dönmez Türkiye 10 177 0.8× 77 0.7× 66 0.7× 23 0.4× 68 1.4× 40 382
Hassan Sibai Canada 11 226 1.1× 59 0.5× 118 1.2× 72 1.2× 87 1.7× 69 369
Sharon Abish Canada 13 132 0.6× 124 1.1× 67 0.7× 65 1.1× 87 1.7× 23 539
Weerapat Owattanapanich Thailand 12 236 1.1× 119 1.1× 175 1.7× 52 0.9× 125 2.5× 72 560
Annalisa Serra Italy 14 134 0.6× 80 0.7× 86 0.9× 60 1.0× 164 3.3× 47 520
Stefano Mancini Italy 9 155 0.7× 60 0.6× 105 1.0× 55 0.9× 59 1.2× 27 419
Roswitha Dickerhoff Germany 12 245 1.1× 114 1.0× 96 1.0× 80 1.4× 48 1.0× 37 556
E Vassallo Italy 11 150 0.7× 66 0.6× 48 0.5× 45 0.8× 60 1.2× 26 379

Countries citing papers authored by Bülent Ündar

Since Specialization
Citations

This map shows the geographic impact of Bülent Ündar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Ündar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Ündar more than expected).

Fields of papers citing papers by Bülent Ündar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Ündar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Ündar. The network helps show where Bülent Ündar may publish in the future.

Co-authorship network of co-authors of Bülent Ündar

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Ündar. A scholar is included among the top collaborators of Bülent Ündar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Ündar. Bülent Ündar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sevindik, Ömür Gökmen, Faize Yüksel, Mehmet Ali Özcan, et al.. (2018). Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?. Turkish Journal of Hematology. 35(4). 271–276. 3 indexed citations
2.
Sevindik, Ömür Gökmen, İnci Alacacıoğlu, Mehmet Ali Özcan, et al.. (2018). A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience. Indian Journal of Hematology and Blood Transfusion. 34(4). 677–683. 3 indexed citations
3.
Özcan, Mehmet Ali, et al.. (2016). Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma. Experimental Hematology. 44(4). 223–230. 6 indexed citations
4.
Saydam, Güray, İbrahim C. Haznedaroğlu, Leylagül Kaynar, et al.. (2016). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase. Expert Opinion on Pharmacotherapy. 17(14). 1851–1858. 4 indexed citations
5.
Sevindik, Ömür Gökmen, İnci Alacacıoğlu, Mehmet Ali Özcan, et al.. (2015). IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort. Clinical Lymphoma Myeloma & Leukemia. 15(6). e101–e104. 4 indexed citations
6.
Alacacıoğlu, İnci, Güner Hayri Özsan, Bahriye Payzın, et al.. (2014). Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers. Chemotherapy. 60(4). 219–223. 23 indexed citations
7.
Özsan, Güner Hayri, et al.. (2012). Kronik Lenfositik Lösemi Hastalarının Genel Klinik Değerlendirilmesi. 26(1). 9–19. 1 indexed citations
8.
Saatçi, Ali Osman, et al.. (2011). Central retinal artery occlusion as the presenting sign of essential thrombocythemia. SHILAP Revista de lepidopterología. 28(2). 146–148. 6 indexed citations
9.
Demırkan, Fatih, İnci Alacacıoğlu, Hayri Özsan, et al.. (2007). The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey. Leukemia & lymphoma. 48(7). 1372–1378. 10 indexed citations
10.
Vural, Filiz, Mehmet Ali Özcan, Güner Hayri Özsan, et al.. (2005). Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines. Leukemia & lymphoma. 46(5). 753–756. 5 indexed citations
11.
Özcan, Mehmet Ali, Ayşe Nur Demiral, Fatih Demırkan, et al.. (2005). Bilateral primary orbital non-Hodgkin's lymphoma in a patient with scleroderma: A case report. Leukemia & lymphoma. 46(8). 1239–1242. 4 indexed citations
12.
Balci, Pınar, Mehmet Ali Özcan, Ahmet Alacacıoğlu, et al.. (2004). Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examination. The Breast. 14(2). 169–174. 1 indexed citations
13.
Özcan, Mehmet Ali, Abdurrahman Çömlekçi, Fatih Demırkan, et al.. (2003). Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thrombosis Research. 110(4). 243–247. 19 indexed citations
14.
Vural, Filiz, Mehmet Ali Özcan, Fatih Demırkan, et al.. (2003). Gingival Involvement in a Patient with CD56+Chronic Myelomonocytic Leukemia. Leukemia & lymphoma. 45(2). 415–418. 10 indexed citations
15.
16.
Akarsu, Mesut, Fatih Demırkan, Fatoş Önen, et al.. (2001). Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease. American Journal of Hematology. 68(4). 225–230. 14 indexed citations
17.
Sercan, Hakki Ogün, et al.. (2000). Consistent Loss of Heterozygosity at 14q32 in Lymphoid Blast Crisis of Chronic Myeloid Leukemia. Leukemia & lymphoma. 39(3-4). 385–390. 12 indexed citations
18.
Ündar, Bülent, et al.. (1999). Flow Cytometric Analysis of Circadian Changes in Platelet Activation Using Anti-Gmp-140 Monoclonal Antibody. Chronobiology International. 16(3). 335–342. 14 indexed citations
19.
Payzın, Bahriye, et al.. (1995). Paraneoplastic Cerebellar Degeneration in Association with Hodgkin’s Disease: A Report of Two Cases. Acta Haematologica. 94(4). 210–213. 6 indexed citations
20.
Ündar, Bülent, et al.. (1994). Coexistence of Chronic Neutrophilic Leukemia with Light Chain Myeloma. Acta Haematologica. 91(1). 32–34. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideyuki Koharazawa Breakdown of academic impact, for papers by Sreejesh Sreedharanunni Breakdown of academic impact, for papers by Ayhan Dönmez Breakdown of academic impact, for papers by Hassan Sibai Breakdown of academic impact, for papers by Sharon Abish Breakdown of academic impact, for papers by Weerapat Owattanapanich Breakdown of academic impact, for papers by Annalisa Serra Breakdown of academic impact, for papers by Stefano Mancini Breakdown of academic impact, for papers by Roswitha Dickerhoff Breakdown of academic impact, for papers by E Vassallo
Rankless by CCL
2026